NIO has entered into a charging network-sharing partnership with GAC, marking the first significant progress since their collaboration agreement a month prior. Yesterday, NIO reported its disappointing Q1 2024 revenue results.
Trump Media & Technology Group Corp. shares dip premarket as CEO Devin Nunes sends fourth congressional letter addressing potential stock manipulation amid persistently high Failures To Deliver (FTDs).
Halozyme Therapeutics surges as it raises FY24 guidance, driven by increased revenue projections and a new European patent for its drug delivery platform.